Actively Recruiting
Evaluating Enlituoae Combined With Anyoupingae and Platinum-Based Chemotherapy Versus Anyoupingae With Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma
Led by Taizhou Mabtech Pharmaceutical Co.,Ltd · Updated on 2026-10-05
362
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of combining Enlituoae with Anyoupingae and platinum-based chemotherapy as a first treatment for advanced, recurrent, or metastatic head and neck squamous cell carcinoma HNSCC. This Phase IIIII trial aims to compare this combination against Anyoupingae plus platinum-based chemotherapy alone, to understand its impact on survival and tumor response. Participants will be randomly assigned to receive either Enlituoae with Anyoupingae and platinum-based chemotherapy or a placebo version of Enlituoae combined with Anyoupingae and platinum-based chemotherapy. The platinum-based chemotherapy includes cisplatin or carboplatin plus albumin-bound paclitaxel. The study is conducted in two parts Phase II with about 60 participants and Phase III with approximately 302 participants, both comparing the treatments over up to two years. During the study, participants will be regularly assessed for overall survival and objective tumor response, along with other outcomes like disease control and progression-free survival. Treatment-related side effects will be monitored from consent until 28 days after the last dose. The entire participation may last up to two years, with frequent evaluations to track the effectiveness and safety of the treatments under investigation.
CONDITIONS
Brief Title
A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Research Team
Z
Zheng Zhang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here